A. , G. D. Gerstein, H. Miller, M. Byington, R. Goff et al., pdf [Consulté le 19 Ministère de la Santé. Pour l'amélioration de la qualité de vie des personnes atteintes de maladies chroniques. Plan Non-observance thérapeutique : causes, conséquences, solutions Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes, ) ADVANCE Collaborative Group, pp.5-6, 2003.

W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele et al., Glucose control and vascular complications in veterans with type 2 diabetes Compliance, observance ou adhésion thérapeutique : de quoi parlons-nous ?) Reach G. La non-observance thérapeutique, révélatrice d'un conflit entre des principes éthiques, patients with type 2 diabetes, pp.2560-72, 2005.

J. A. Cramer, A. Roy, A. Burell, C. Fairchild, M. Fuldeore et al., Medication Compliance and Persistence: Terminology and Definitions, Value in Health, vol.11, issue.1, pp.44-51, 2008.
DOI : 10.1111/j.1524-4733.2007.00213.x

). Matteo and M. , Variations in patient's adherence to medical recommendations : a quantitative review of 50 years of research, Med Care, vol.42, issue.11, pp.200-209, 2004.

B. Allenet, M. Baudrant, A. Lehmann, A. Gauchet, M. Roustit et al., Comment ??valuer l???adh??sion m??dicamenteuse??? Le point sur les m??thodes, Annales Pharmaceutiques Fran??aises, vol.71, issue.2, pp.135-176, 2013.
DOI : 10.1016/j.pharma.2012.10.001

X. Girerd, O. Hanon, K. Anagnostopoulos, C. Ciupek, J. Mourad et al., Evaluation de l'observance du traitement antihypertenseur par un questionnaire : mise au point et utilisation dans un service spécialisé, Presse Med, vol.30, issue.1521, pp.1044-1092, 2001.

D. Morisky, L. Green, and D. Levine, Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence, Medical Care, vol.24, issue.1, pp.67-74, 1986.
DOI : 10.1097/00005650-198601000-00007

F. Bizouard and C. Jungers, Clinique de l'Obervance, l'exemple des diabètes. Paris : John Libbey Eurotext editions Evaluation de la connaissance des indications des traitements chroniques en médecine générale et de la relation médecin-malade, 2006.

S. Halimi, Enquête Diabasis : comment le patient diabétique perçoit son traitement et son suivi ?

J. Anandamanoharan, N. Britten, and N. Morgan, Observance et médecine générale : peut-on dépister les problèmes d'observance chez les patients atteints de pathologies chroniques ? Thèse pour le Doctorat de Médecine Resisting medicines : a synthesis of qualitative studies of medicine taking, Soc Sci Med, vol.61, issue.221, pp.133-55, 2005.

W. Polonsky, L. Fisher, S. Guzman, L. Villa-caballero, and S. Edelman, Psychological Insulin Resistance in Patients With Type 2 Diabetes: The scope of the problem, Diabetes Care, vol.28, issue.10, pp.2543-2546, 2005.
DOI : 10.2337/diacare.28.10.2543

J. Gonzalez, M. Peyrot, L. Mccarl, E. Collins, L. Serpa et al., Depression and Diabetes Treatment Nonadherence: A Meta-Analysis, Diabetes Care, vol.31, issue.12, pp.2398-403, 2008.
DOI : 10.2337/dc08-1341

B. Wallston and K. Wallston, Penser autrement le comportement d'adhésion du patient au traitement médicamenteux : modification d'une intervention éducative ciblant le patient et ses médicaments dans le but de développer des compétences mobilisables au quotidien Locus of control and health : a review of the literature. Health education monographs, pp.107-124, 1978.

A. Claxton, J. Cramer, and C. Pierce, Observance thérapeutique : ses facteurs et ses enjeux A systematic review of the association between dose regimens and medication compliance, Thèse pour obtenir le grade de Docteur en Médecine, pp.1296-310, 2001.

K. Zolnierek, D. Matteo, and D. , Physician Communication and Patient Adherence to Treatment, Medical Care, vol.47, issue.8, pp.826-860, 2009.
DOI : 10.1097/MLR.0b013e31819a5acc

J. Odabachian, A. Michault, H. Bihan, C. Paulino, R. Cohen et al., Les médecins généralistes et l'observance thérapeutique des maladies chroniques : états des lieux et perspectives Thèse d'exercice de Médecine Générale Impatience is an independent determinant of poor diabetes control, Diabetes Metab, vol.37, issue.326, pp.497-504, 2011.

J. Piette, M. Heisler, S. Krein, and E. Kerr, The Role of Patient-Physician Trust in Moderating Medication Nonadherence Due to Cost Pressures, Archives of Internal Medicine, vol.165, issue.15, pp.1749-55, 2005.
DOI : 10.1001/archinte.165.15.1749

W. Gellad, J. Grenard, and Z. Marcum, A Systematic Review of Barriers to Medication Adherence in the Elderly: Looking Beyond Cost and Regimen Complexity, The American Journal of Geriatric Pharmacotherapy, vol.9, issue.1, pp.11-23, 2011.
DOI : 10.1016/j.amjopharm.2011.02.004

). Connor, P. Sperl-hillen, J. Johnson, and P. , Clinical inertia and outpatient medical errors, Advances in Patient Safety, vol.2, issue.37, pp.293-308, 2005.

). Schectman, J. Nadkarni, M. Voss, and J. , Résultats du module « information et éducation » Rapport concernant : l'information et l'éducation reçues par les personnes diabétiques, les pratiques éducatives des médecins, ainsi que les attentes des personnes diabétiques et des médecins The association between diabetes metabolic control and drug adherence in an indigent population, Décembre Diabetes Care, vol.89, issue.25, pp.1015-1036, 2002.

S. Kogut, S. Andrade, C. Willey, and E. Larrat, Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation) Pharmacoepidemiology and Drug Safety, 2004.

D. Lau and P. Nau, Oral Antihyperglycemic Medication Nonadherence and Subsequent Hospitalization Among Individuals With Type 2 Diabetes, Diabetes Care, vol.27, issue.9, pp.2149-53, 2004.
DOI : 10.2337/diacare.27.9.2149

P. Ho, J. Rumsfeld, F. Masoudi, D. Mcclure, M. Plomondon et al., Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes Mellitus, Archives of Internal Medicine, vol.166, issue.17, pp.1836-1877, 2006.
DOI : 10.1001/archinte.166.17.1836

V. Zhu, W. Tu, M. Rosenman, and J. Overhage, Nonadherence to Oral Antihyperglycemic Agents : Subsequent Hospitalization and Mortality among Patients with Type 2 Diabetes in Clinical Practice, Stud Health Technol Inform, vol.216, issue.43, pp.60-63, 2015.

R. Horwitz, C. Viscoli, L. Berkman, R. Donaldson, S. Horwitz et al., Treatment adherence and risk of death after a myocardial infarction, The Lancet, vol.336, issue.8714, pp.542-547, 1990.
DOI : 10.1016/0140-6736(90)92095-Y

S. Simpson, D. Eurich, S. Majumdar, R. Padwal, R. Tsuyuki et al., A meta-analysis of the association between adherence to drug therapy and mortality, BMJ, vol.333, issue.7557, pp.15-46, 2006.
DOI : 10.1136/bmj.38875.675486.55

J. Sacareau, A. Barnett, R. Brice, W. Hanif, J. James et al., Hypoglycémies iatrogènes sévères chez les patients diabétiques de type 2 : fréquence de survenue, circonstances et coûts médico-économiques. Thèse pour le diplôme d'Etat de Docteur en Pharmacie Increasing awareness of hypoglycaemia in patients with type 2 diabetes treated with oral agents, Faculté de Grenoble. Curr Med Res Opin, vol.119, issue.2911, pp.1503-1516, 2012.

D. Budnitz, M. Lovegrove, N. Shahab, and C. Richards, Emergency Hospitalizations for Adverse Drug Events in Older Americans, New England Journal of Medicine, vol.365, issue.21, pp.2002-2014, 2011.
DOI : 10.1056/NEJMsa1103053

C. Miller, L. Phillips, D. Ziemer, D. Gallina, C. Cook et al., Hypoglycemia in Patients With Type 2 Diabetes Mellitus, Archives of Internal Medicine, vol.161, issue.13, pp.1653-1659, 2001.
DOI : 10.1001/archinte.161.13.1653

C. Edridge, A. Dukley, D. Hodicoat, T. Rose, L. Grey et al., Prevalence and incidence oh hypoglycaemia in 532 542 people with diabetes on oral therapies and insulin : a systematic review and meta analysis of population based studies, Plos One, vol.10, issue.566, 2015.

P. Vexiau, P. Mavros, G. Krishnarajah, R. Lyu, and D. Yn, Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France, Diabetes, Obesity and Metabolism, vol.19, issue.s1, pp.16-24, 2008.
DOI : 10.1210/jc.79.6.1659

W. Knowler, E. Barrett-connor, S. Fowler, R. Hamman, J. Lachin et al., Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, New Engl J Med, vol.346, issue.60, pp.393-403, 2002.

J. Tuomilehto, J. Lindstrom, A. Louheranta, M. Mannelin, M. Rastas et al., Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance, New England Journal of Medicine, vol.344, issue.18, pp.1343-50, 2001.
DOI : 10.1056/NEJM200105033441801

D. Williamson, T. Thompson, M. Thun, D. Flanders, E. Pamuk et al., Intentional weight loss and mortality among overweight individuals with diabetes, Diabetes Care, vol.23, issue.10, pp.1499-504, 2000.
DOI : 10.2337/diacare.23.10.1499

M. Marcelli, M. Padden, K. Kellick, T. Duhancik, M. Wilhardt et al., Recommandations de bonne pratique <http://www.has-sante.fr/portail Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets, Janvier J Manag Care Pharm, vol.25, issue.9, pp.256-62, 2003.

D. Sherifali, K. Nerenberg, E. Pullenayegum, J. Cheng, and H. Gerstein, The effect of oral antidabetic agents on A1C levels : a systematic review and meta-analysis, Diabetes Care, vol.33, issue.658, pp.859-64, 2010.

M. Harris, Frequency of Blood Glucose Monitoring in Relation to Glycemic Control in Patients With Type 2 Diabetes, Diabetes Care, vol.24, issue.6, pp.979-82, 2001.
DOI : 10.2337/diacare.24.6.979

A. Karter, M. Parker, H. Moffet, A. Ahmed, A. Ferrara et al., Missed Appointments and Poor Glycemic Control, Medical Care, vol.42, issue.2, pp.110-115, 2004.
DOI : 10.1097/01.mlr.0000109023.64650.73

S. Vijan, N. Stuart, J. Fitzgerald, D. Ronis, R. Hayward et al., Barriers to following dietary recommendations in Type 2 diabetes, Diabetic Medicine, vol.19, issue.1, pp.32-40, 2005.
DOI : 10.1016/0304-4076(85)90158-7

M. Pollack, F. Purayidathilb, S. Bolgec, and S. Williams, Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life, Diabetes Research and Clinical Practice, vol.87, issue.2, pp.204-210, 2010.
DOI : 10.1016/j.diabres.2009.11.023

M. Bron, M. Marynchenko, H. Yang, A. Yu, and E. Wu, Hypoglycemia, Treatment Discontinuation, and Costs in Patients with Type 2 Diabetes Mellitus on Oral Antidiabetic Drugs, Postgraduate Medicine, vol.352, issue.9131, 2012.
DOI : 10.2337/dc08-9026

A. Guisasola, F. , T. Povedano, S. Krishnarajah, G. Lyu et al., Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study, Diabetes, Obesity and Metabolism, vol.38, issue.s1, pp.25-32, 2008.
DOI : 10.1016/S0026-0495(03)00190-2

J. Cramer, A Systematic Review of Adherence With Medications for Diabetes, Diabetes Care, vol.27, issue.5, pp.1218-1242, 2004.
DOI : 10.2337/diacare.27.5.1218

K. Iglay, S. Cartier, V. Rosen, V. Zarotsky, S. Rajpathak et al., Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes, Current Medical Research and Opinion, vol.31, issue.7, pp.1283-96, 2015.
DOI : 10.1185/03007995.2015.1053048

G. Dailey, M. Kim, and J. Lian, Patient Compliance and Persistence with Anti-Hyperglycemic Therapy: Evaluation of a Population of Type 2 Diabetic Patients, Journal of International Medical Research, vol.22, issue.1, pp.71-80, 2002.
DOI : 10.1177/147323000203000111

I. Lerman, L. Lozano, A. Villa, S. Hernández-jiménez, K. Weinger et al., Psychosocial factors associated with poor diabetes self-care management in a specialized Center in Mexico City, Biomedicine & Pharmacotherapy, vol.58, issue.10, pp.566-70, 2004.
DOI : 10.1016/j.biopha.2004.09.003

J. Stephens, B. Blak, K. Gold, M. Botteman, C. Pashos et al., Persistence patterns with oral hypoglycemic agents in type 2 diabetes, J Clin Outcomes Manage, vol.9, issue.76, pp.491-499, 2002.

L. Guenette, J. Moisan, M. Breton, C. Sirois, and J. Grégoire, Difficulty adhering to antidiabetic treatment: Factors associated with persistence and compliance, Diabetes & Metabolism, vol.39, issue.3, pp.250-257, 2013.
DOI : 10.1016/j.diabet.2012.12.005

Y. Rozenfeld, J. Hunt, C. Plauschinat, and K. Wong, Oral antidiabetic adherence and glycemic control in managed care, Am J Manag Care, vol.14, issue.782, pp.71-76, 2008.

P. Guillausseau, Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice, Diabetes & Metabolism, vol.29, issue.1, pp.79-81, 2003.
DOI : 10.1016/S1262-3636(07)70011-3

K. Krapek, K. King, S. Warren, K. George, D. Caputo et al., in Type 2 Diabetes, Annals of Pharmacotherapy, vol.8, issue.1, pp.1357-62, 2004.
DOI : 10.2337/diacare.25.6.1015

D. Lawrence, K. Ragucci, L. Long, E. Parris, and L. Helfer, Relationship of Oral Antihyperglycemic (Sulfonylurea or Metformin) Medication Adherence and Hemoglobin A1c Goal Attainment for HMO Patients Enrolled in a Diabetes Disease Management Program, Journal of Managed Care Pharmacy, vol.12, issue.6, pp.466-71, 2006.
DOI : 10.18553/jmcp.2006.12.6.466

P. Donnan, T. Macdonald, and A. Morrist, Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study, Diabetic Medicine, vol.313, issue.4, pp.279-284, 2002.
DOI : 10.1046/j.1464-5491.2000.00327.x

R. Grant, N. Devita, D. Singer, and J. Meigs, Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes, Diabetes Care, vol.26, issue.5, pp.1408-1420, 2003.
DOI : 10.2337/diacare.26.5.1408

A. Paes, A. Bakker, and C. Soe-agnie, Impact of Dosage Frequency on Patient Compliance, Diabetes Care, vol.20, issue.10, pp.1512-1519, 1997.
DOI : 10.2337/diacare.20.10.1512

C. Melikian, T. White, A. Vanderplas, C. Dezii, and E. Chang, Adherence to oral antidiabetic therapy in a managed care organization: A comparison of monotherapy, combination therapy, and fixed-dose combination therapy, Clinical Therapeutics, vol.24, issue.3, pp.460-467, 2002.
DOI : 10.1016/S0149-2918(02)85047-0

L. Blonde, J. Wogen, C. Kreilick, and A. Seymour, Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin, Diabetes, Obesity and Metabolism, vol.33, issue.6, pp.424-455, 2003.
DOI : 10.1016/S0140-6736(97)06234-X

S. Han, K. Iglay, M. Davies, Q. Zhang, and L. Radican, Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis, Current Medical Research and Opinion, vol.28, issue.6, pp.969-77, 2012.
DOI : 10.1185/03007995.2012.684045

S. Bocuzzi, J. Wogen, J. Fox, J. Sung, A. Shah et al., Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population, Diabetes Care, vol.24, issue.8, pp.1411-1416, 2001.
DOI : 10.2337/diacare.24.8.1411

J. Chao, D. Nau, and J. Aikens, Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus, Clinical Therapeutics, vol.29, issue.1, pp.177-80, 2007.
DOI : 10.1016/j.clinthera.2007.01.014

H. Florez, J. Luo, S. Castillo-florez, G. Mitsi, J. Hanna et al., Impact of Metformin-Induced Gastrointestinal Symptoms on Quality of Life and Adherence in Patients with Type 2 Diabetes, Postgraduate Medicine, vol.29, issue.9, pp.112-120, 2010.
DOI : 10.1186/1477-7525-1-4

S. Vijan, R. Hayward, D. Ronis, and T. Hofer, BRIEF REPORT: The burden of diabetes therapy, Journal of General Internal Medicine, vol.21, issue.suppl 1, pp.479-82, 2005.
DOI : 10.1111/j.1525-1497.2005.0117.x

P. Ciechanowski, W. Katon, J. Russo, and E. Walker, The Patient-Provider Relationship: Attachment Theory and Adherence to Treatment in Diabetes, American Journal of Psychiatry, vol.158, issue.1, pp.29-35, 2001.
DOI : 10.1176/appi.ajp.158.1.29

S. Sulaiman, M. Hassali, A. Shafie, S. Sundram, R. Al-nuri et al., Programmes de formation continue pour professionnels de soins dans le domaine de la prévention des maladies chroniques [En ligne] : http://www.euro.who.int/__data Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes, 94) Organisation Mondiale de la Santé. Education thérapeutique du patient, pp.1028-1063, 1998.

D. Browne, L. Avery, B. Turner, D. Kerr, and D. Cavan, What do patients with diabetes know about their tablets ? Diabet Med, pp.528-559, 2000.

F. Piñeiro, M. Donis, M. Torres, D. Orozco, J. Merino et al., Factors involved in noncompliance with drug treatment in non-insulin dependent diabetes mellitus, Atem Primaria, vol.20, issue.978, pp.415-435, 1997.

T. Deakin, M. Shane, C. Cade, J. Williams, R. Norris et al., Group based training for self-management strategies in people with type 2 diabetes mellitus Self-management training for adults with type 2 diabetes : a meta-analysis of the effect on glycemic control, CD003417. (99), pp.1159-71, 2002.

M. Trento, P. Passera, V. Miselli, M. Bajardi, E. Borgo et al., Evaluation of the locus of control in patients with type 2 diabetes after long-term management by group care, Diabetes & Metabolism, vol.32, issue.1, pp.77-81, 2006.
DOI : 10.1016/S1262-3636(07)70250-1

E. Vermeire, J. Wens, P. Van-royen, Y. Biot, H. Hearnshaw et al., Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus, Cochrane Database Syst Rev, vol.18, issue.101, 2005.

S. Sapkota, J. Brien, J. Greenfield, and P. Aslani, A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes???Impact on Adherence, PLOS ONE, vol.30, issue.2, p.118296, 2015.
DOI : 10.1371/journal.pone.0118296.s010

R. Anderson and M. Funnell, Patient empowerment: Myths and misconceptions, Patient Education and Counseling, vol.79, issue.3, pp.277-282, 2010.
DOI : 10.1016/j.pec.2009.07.025

M. Hernandez-tejada, J. Campbell, R. Walker, B. Smalls, K. Davis et al., Diabetes Empowerment, Medication Adherence and Self-Care Behaviors in Adults with Type 2 Diabetes, Diabetes Technology & Therapeutics, vol.14, issue.7, pp.630-634, 2012.
DOI : 10.1089/dia.2011.0287

D. Schillinger, J. Piette, K. Grumbach, F. Wang, C. Wilson et al., Closing the Loop, Archives of Internal Medicine, vol.163, issue.1, pp.83-90, 2003.
DOI : 10.1001/archinte.163.1.83

D. Simon, F. Bourdillon, R. Gagnayre, A. Grimaldi, and P. Traynard, Education thérapeutique : prévention et maladies chroniques, Abrégés, vol.400, issue.106, 2013.

H. Vignon-zomahoun, M. De-bruin, L. Guillaumie, J. Moisan, J. Grégoire et al., Effectiveness and Content Analysis of Interventions to Enhance Oral Antidiabetic Drug Adherence in Adults with Type 2 Diabetes: Systematic Review and Meta-Analysis, Value in Health, vol.18, issue.4, pp.530-540, 2015.
DOI : 10.1016/j.jval.2015.02.017

P. Levy, Comment favoriser l'observance dans le diabète de type 2 ? Revue du Praticien Med générale, pp.672-673, 2004.

S. Antoine, D. Pieper, T. Mathes, and M. Eikermann, Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials, BMC Endocrine Disorders, vol.15, issue.1, p.53, 2014.
DOI : 10.1136/qshc.2004.012153

P. Ricci, P. Blotière, A. Weil, D. Simon, P. Tuppin et al., Diabète traité : quelles évolutions entre, BEH, issue.11116, pp.42-43425, 2000.

D. La, P. Diabete, and . Entre, oublier de prendre votre médicament ? -Vous arrive-t-il de négliger votre traitement de temps à autres ? -Vous arrive-t-il de stopper votre traitement quand vous vous sentez mieux ? -Vous arrive-t-il de stopper votre traitement si vous vous sentez mal en le prenant ? » Interprétation : -Si 0 « oui » : bonne observance, Si 1 ou 2 « oui » : observance moyenne, p.90, 2000.

?. Jamais and /. , Moins d'une fois par semaine / ? Plusieurs fois par semaine / ? De façon quotidienne 13/ Suivez-vous un régime diététique particulier ?

?. Oui, de façon stricte / ? Oui mais avec quelques écarts / ? Ecarts fréquents / ? Non 14/ Quel traitement antidiabétique oral prenez-vous ?